Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

NCT ID: NCT06498310

Last Updated: 2024-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-08

Study Completion Date

2025-11-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Invasive Fungal Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient ≥18 years old
* Heart transplant
* Invasive fungal infection with filamentous fungi during the period from January 1, 2008 to December 31, 2022
* Proven or probable infection with filamentous fungi according to EORTC/MSGERC criteria (20):

* Invasive aspergillosis
* Mucormycosis
* Fusarium wilt
* Scedosporiosis
* Other filamentous fungus infection
* Subject who has not expressed, after information, his opposition to the reuse of his data for the purposes of this research.

Exclusion Criteria

* Patient having expressed his opposition to participating in the study
* Patient not having a liver transplant
* Subject under guardianship, curatorship or safeguard of justice.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

François DANION, MD

Role: CONTACT

33 3 69 55 15 88

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

François DANION, MD

Role: primary

33 3 69 55 15 88

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9066

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sautour PHRC IR 2008
NCT02859831 COMPLETED
King's Invasive Aspergillosis Study II
NCT02875743 COMPLETED PHASE4